NCT00596687View on ClinicalTrials.gov

Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

July 31, 2013

Conditions
Type 2 DiabetesInpatient Hyperglycemia
Interventions
DRUG

Insulin glargine

Insulin glargine once daily SQ

DRUG

Regular insulin

Sliding scale regular insulin SQ four-times daily before meals or every 6 hours if patient NPO

DRUG

Insulin glulisine

scheduled glulisine given SQ at mealtime TID; none given if patient NPO

Trial Locations (2)

30303

Grady Memorial Hospital, Atlanta

30324

Emory University Hospital, Atlanta

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Emory University

OTHER

NCT00596687 - Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery | Biotech Hunter | Biotech Hunter